基本情報
- CAS
23930-19-0- 標準SMILES
CC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4C[C@H](O)CC[C@]4(C)[C@H]3C(=O)C[C@]12C- InChIKey
DUHUCHOQIDJXAT-OLVMNOGESA-N- 分子式
- C21H32O3
- 平均分子量
- 332.5 g/mol
- 単同位体質量
- 332.23514488
概要
Alphaxolone is a corticosteroid hormone.
名称と識別子
- 優先名称
- Alphaxalone
- IUPAC
- (3R,5S,8S,9S,10S,13S,14S,17S)-17-acetyl-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-11-one
- 現地名
- アルファキサロン
- 英語名
- Alfaxalone
- 分子式
- C21H32O3
- 分子量
- 332.48
名称と別名
名称をさらに表示
データベース識別子
- CAS
23930-19-0- PubChem CID
- 104845
- DTXSID
DTXSID9022576- ChEMBL
CHEMBL190279- ChEBI
CHEBI:34531- UNII
- BD07M97B2A
- EC Number
- 636-625-6
- Nikkaji
- J3.157G
物性
構造計算による物性
- XLogP
- 3.2
- 極性表面積
- 54.4 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 3
- 回転可能結合数
- 1
- 重原子数
- 24
- 形式電荷
- 0
- 複雑度
- 569
実験および物理化学的性質
Drugs
DEA Schedule IV Controlled Substance -> Depressants
Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds
Pharmaceuticals -> Listed in ZINC15
Animal Drugs
FDA approved animal drugs -> Active ingredient
Pharmaceuticals -> UK Veterinary Medicines Directorate List
物理化学的性質
- 融点
- 172 · 172-174°
- 比旋光度
- 26 · D26 +113.4° (c = 1.2 in chloroform).
- 沸点
- 409.59 °C · 409.59°C (rough estimate)
- 比重(密度)
- 1.0834 · 1.0834 (rough estimate)
- 屈折率
- 1.5192 · 1.5192 (estimate)
- 貯蔵温度
- Store at RT
- 溶解性
- 5 mg/mL · クロロホルム:5mg/mL 無色透明
- 外見
- 粉
- 酸解離定数(Pka)
- 15.05 · 15.05±0.70(Predicted)
- 色
- 白い
- InChI
- InChI=1/C21H32O3/c1-12(22)16-6-7-17-15-5-4-13-10-14(23)8-9-20(13,2)19(15)18(24)11-21(16,17)3/h13-17,19,23H,4-11H2,1-3H3/t13-,14+,15-,16+,17-,19+,20-,21+/s3
- InChIKey
- DUHUCHOQIDJXAT-YYJIQYHHNA-N
- SMILES
- [C@]12([H])C(=O)C[C@]3(C)[C@H](CC[C@@]3([H])[C@]1([H])CC[C@@]1([H])C[C@H](O)CC[C@]21C)C(=O)C |&1:0,5,7,10,12,16,19,23,r|
安全と法規制
GHS分類
GHS Classification
Danger
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
P264, P270, P301+P316, P321, P330, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 41 reports by companies from 1 notifications to the ECHA C&L Inventory.
危険有害性情報
Regulatory Information
DEA schedule IV controlled substance
Alfaxalone: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
安全データ
- wgk
- 3
- rtecs
- TU4157800
- ridadr
- UN 2811 6.1/PG 3
- 毒性
- LD50 i.v. in mice: 43 mg/kg (Al-Khawashki)
- risk_code
- 22
- hazard_code
- Xn
- safety_code
- 22-36
化学と産業
薬理情報
ATC Code
N - Nervous system
QN - Nervous system
MeSH Pharmacological Classification
Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site.
Endogenous compounds or drugs that affect neuronal excitability through modulation of specific ionotropic receptors (e.g., GABA-A RECEPTORS). Endogenous neurosteroids are steroid hormones de novo synthesized by neurons and glial cells from steroid metabolite precursors (e.g., PREGNENOLONE).
応用分野
使用Anesthetic;nociception blocker
上流・下流製品情報
上流原料
サプライヤー64 社
関連反応
化合物ノート
読み込み中…